Chinese herb couple against diabetes: integrating network pharmacology and mechanism study

References

• Abdel-Moneim, A., Bakery, H. H., & Allam, G. (2018). The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomedicine & Pharmacotherapy, 101, 287–292. https://doi.org/10.1016/j.biopha.2018.02.103
   PubMed Web of Science ®Google Scholar
• Akbari, M., & Hassan-Zadeh, V. (2018). IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology, 26(3), 685–698. https://doi.org/10.1007/s10787-018-0458-0
   PubMed Web of Science ®Google Scholar
• Albury-Warren, T. M., Pandey, V., Spinel, L. P., Masternak, M. M., & Altomare, D. A. (2016). Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1. Journal of Endocrinology, 228(1), 49–59. https://doi.org/10.1530/JOE-15-0288
   PubMed Web of Science ®Google Scholar
• Archundia Herrera, M. C., Subhan, F. B., & Chan, C. B. (2017). Dietary patterns and cardiovascular disease risk in people with type 2 diabetes. Current Obesity Reports, 6(4), 405–413. https://doi.org/10.1007/s13679-017-0284-5
   PubMed Web of Science ®Google Scholar
• Cai, Y., Liu, L., Xia, M., Tian, C., Wu, W., Dong, B., & Chu, X. (2022). SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models. International Journal of Pharmaceutics, 614, 121461. https://doi.org/10.1016/j.ijpharm.2022.121461
   PubMed Web of Science ®Google Scholar
• Chandramohan, R., & Pari, L. (2021). Antihyperlipidemic effect of tyrosol, a phenolic compound in streptozotocin-induced diabetic rats. Toxicology Mechanisms and Methods, 31(7), 507–516. https://doi.org/10.1080/15376516.2021.1926030
   PubMed Web of Science ®Google Scholar
• Chen, Q., & Lv, M. (2020). Clinical study of modified Huangqi Guizhi Wuwu decoction combined with western medicine in the treatment of diabetic peripheral neuropathy. China Journal of Pharmaceutical Economics, 15(03), 63–66.
   Google Scholar
• Chen, G. M., Zhong, X. Y., Zhao, J. L., Huang, Y., Lin, H. R., Liang, M. Z., Liu, Y. Y., Yu, J. W., Huang, R. L., & Liu, M. (2018). Prediction of targets and mechanism of Astragalus and Gui Zhi Wu Wu Wu Tang for the treatment of diabetic peripheral neuropathy. Chinese Journal of Experimental Formulas, 24(08), 214–222.
   Google Scholar
• Dandawate, S., Williams, L., Joshee, N., Rimando, A. M., Mittal, S., Thakur, A., Lum, L. G., & Parajuli, P. (2012). Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-beta1 activity. Cancer Immunology, Immunotherapy: CII, 61(5), 701–711. https://doi.org/10.1007/s00262-011-1130-3
   PubMed Web of Science ®Google Scholar
• Dong, B., Chen, J., Cai, Y., Wu, W., & Chu, X. (2022). In vitro and in vivo evaluation of cinnamaldehyde Microemulsion-Mucus interaction. Journal of Food Biochemistry, 46(10), e14307.
   PubMed Web of Science ®Google Scholar
• Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P. A., Schuit, F. C., & Donath, M. Y. (2008). Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proceedings of the National Academy of Sciences of the USA, 105(35), 13163–13168. https://doi.org/10.1073/pnas.0801059105
   PubMed Web of Science ®Google Scholar
• GBD 2021 Diabetes Collaborators. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021 [published correction appears in Lancet. Lancet (London, England), 402(10397), 203–234. https://doi.org/10.1016/S0140-6736(23)01301-6
   PubMed Web of Science ®Google Scholar
• Goodsell, D. S., Zardecki, C., Di Costanzo, L., Duarte, J. M., Hudson, B. P., Persikova, I., Segura, J., Shao, C., Voigt, M., Westbrook, J. D., Young, J. Y., & Burley, S. K. (2020). RCSB Protein Data Bank: Enabling biomedical research and drug discovery. Protein Science, 29(1), 52–65. https://doi.org/10.1002/pro.3730
   PubMed Web of Science ®Google Scholar
• Guo, W., Huang, J., Wang, N., Tan, H. Y., Cheung, F., Chen, F., & Feng, Y. (2019). Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula Zuojin Pill in suppressing hepatocellular carcinoma. Frontiers in Pharmacology, 10, 1185. https://doi.org/10.3389/fphar.2019.01185
   PubMed Web of Science ®Google Scholar
• Hamilton, K. E., Rekman, J. F., Gunnink, L. K., Busscher, B. M., Scott, J. L., Tidball, A. M., Stehouwer, N. R., Johnecheck, G. N., Looyenga, B. D., & Louters, L. L. (2018). Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1. Biochimie, 151, 107–114. https://doi.org/10.1016/j.biochi.2018.05.012
   PubMed Web of Science ®Google Scholar
• Hu, Y., Wang, J., Zhou, Y., Xie, H., Yan, X., Chu, X., Chen, W., Liu, Y., Wang, X., Wang, J., Zhang, A., & Han, S. (2019). Peptidomics analysis of umbilical cord blood reveals potential preclinical biomarkers for neonatal respiratory distress syndrome. Life Sciences, 236, 116737. https://doi.org/10.1016/j.lfs.2019.116737
   PubMed Web of Science ®Google Scholar
• Huang, C. Y., Wu, C. L., Yang, Y. C., Chang, J. W., Kuo, Y. C., Cheng, Y. Y., Wu, J. S., Lee, C. C., & Guo, H. R. (2015). Association between dioxin and diabetes mellitus in an endemic area of exposure in Taiwan: A population-based study. Medicine, 94(42), e1730. https://doi.org/10.1097/MD.0000000000001730
   PubMed Web of Science ®Google Scholar
• Javeed, N., & Matveyenko, A. V. (2018). Circadian etiology of type 2 diabetes mellitus. Physiology (Bethesda, Md.), 33(2), 138–150. https://doi.org/10.1152/physiol.00003.2018
   PubMed Web of Science ®Google Scholar
• Jia, W., Weng, J., & Zhu, D. (2019). Standards of medical care for type 2 diabetes in China 2019. Diabetes Metabolism Research and Reviews, 35(6), e3158.
   PubMed Web of Science ®Google Scholar
• Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. Journal of Epidemiology and Global Health, 10(1), 107–111. https://doi.org/10.2991/jegh.k.191028.001
   PubMed Web of Science ®Google Scholar
• Leach, M. J., & Kumar, S. (2012). Cinnamon for diabetes mellitus. Cochrane Database of Systematic Reviews, 2012(9), CD007170.
   PubMedGoogle Scholar
• Li, M., Han, B., Zhao, H., Xu, C., Xu, D., Sieniawska, E., Lin, X., & Kai, G. (2022). Biological active ingredients of Astragali radix and its mechanisms in treating cardiovascular and cerebrovascular diseases. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 98, 153918. https://doi.org/10.1016/j.phymed.2021.153918
   PubMed Web of Science ®Google Scholar
• Lind, P. M., & Lind, L. (2018). Endocrine-disrupting chemicals and risk of diabetes: An evidence-based review. Diabetologia, 61(7), 1495–1502. https://doi.org/10.1007/s00125-018-4621-3
   PubMed Web of Science ®Google Scholar
• Li, X. Y., Shen, L., & Ji, H. F. (2019). Astragalus alters gut-microbiota composition in type 2 diabetes mice: Clues to its pharmacology. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 771–778. https://doi.org/10.2147/DMSO.S203239
   PubMed Web of Science ®Google Scholar
• Liu, L., Cao, W., Xia, M., Tian, C., Wu, W., Cai, Y., & Chu, X. (2022). Self-emulsifying drug delivery system enhances tissue distribution of cinnamaldehyde by altering the properties of the mucus layer. AAPS PharmSciTech, 23(7), 261. https://doi.org/10.1208/s12249-022-02416-4
   PubMed Web of Science ®Google Scholar
• Liu, L., Chu, X., Tian, C., Xia, M., Zhang, L., Jiang, J., & Gui, S. (2021). Chemo proling and simultaneous analysis of different combinations of sinomenii caulis and ramulus cinnamomi using UHPLC-Q-TOF-MS, GC-MS and HPLC methods. Journal of Chromatographic Science, 59(7), 606–617. https://doi.org/10.1093/chromsci/bmab048
   PubMed Web of Science ®Google Scholar
• Liu, Y., Deng, J., & Fan, D. (2019). Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway. Food & Function, 10(5), 2538–2551. https://doi.org/10.1039/c9fo00095j
   PubMed Web of Science ®Google Scholar
• Liu, K., Yang, Y., Zhou, F., Xiao, Y., & Shi, L. (2020). Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy and relieves hyperalgesia in diabetic rats. Neuroreport, 31(9), 644–649. https://doi.org/10.1097/WNR.0000000000001461
   PubMed Web of Science ®Google Scholar
• Li, C., Zhang, K., Liu, L., Shen, J., Wang, Y., Tan, Y., Feng, X., Liu, W., Zhang, H., & Sun, J. (2023). Study of the mechanism of astragali radix in treating type 2 diabetes mellitus and its renal protection based on enzyme activity, network pharmacology, and experimental verification. Molecules (Basel, Switzerland), 28(24), 8030. https://doi.org/10.3390/molecules28248030
   PubMed Web of Science ®Google Scholar
• Matsuda, S., Nakanishi, A., Wada, Y., & Kitagishi, Y. (2013). Roles of PI3K/AKT/PTEN pathway as a target for pharmaceutical therapy. The Open Medicinal Chemistry Journal, 7(1), 23–29. https://doi.org/10.2174/1874104501307010023
   PubMedGoogle Scholar
• Melmer, A., & Laimer, M. (2016). Treatment goals in diabetes. Endocrine Development, 31, 1–27. https://doi.org/10.1159/000439364
   PubMedGoogle Scholar
• Miossec, P., & Kolls, J. K. (2012). Targeting IL-17 and TH17 cells in chronic inflammation. Nature Reviews. Drug Discovery, 11(10), 763–776. https://doi.org/10.1038/nrd3794
   PubMed Web of Science ®Google Scholar
• Naz, S., Shafique, N., Sharif, S., Manzoor, F., Saifi, S. Z., Firasat, S., & Kaul, H. (2020). Association of interleukin 10 (IL-10) gene with type 2 diabetes mellitus by single nucleotide polymorphism of its promotor region G/A 1082. Critical Reviews in Eukaryotic Gene Expression, 30(4), 285–289. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2020030714
   PubMed Web of Science ®Google Scholar
• Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. (2022). Network pharmacology: Curing causal mechanisms instead of treating symptoms. Trends in Pharmacological Sciences, 43(2), 136–150. https://doi.org/10.1016/j.tips.2021.11.004
   PubMed Web of Science ®Google Scholar
• Ojo, O. (2019). Dietary intake and type 2 diabetes. Nutrients, 11(9), 2177. https://doi.org/10.3390/nu11092177
   PubMed Web of Science ®Google Scholar
• Oza, M. J., & Kulkarni, Y. A. (2018). Formononetin treatment in type 2 diabetic rats reduces insulin resistance and hyperglycemia. Frontiers in Pharmacology, 9, 739. https://doi.org/10.3389/fphar.2018.00739
   PubMed Web of Science ®Google Scholar
• Oza, M. J., & Kulkarni, Y. A. (2019). Formononetin attenuates kidney damage in type 2 diabetic rats. Life Sciences, 219, 109–121. https://doi.org/10.1016/j.lfs.2019.01.013
   PubMed Web of Science ®Google Scholar
• Papadopoulou, S. K., Papandreou, D., Tassoulas, E., Biskanaki, F., Kalogiannis, S., & Hassapidou, M. N. (2020). Gender and exercise in relation to obesity in greek elderly population. International Journal of Environmental Research and Public Health, 17(18), 6575.
   PubMed Web of Science ®Google Scholar
• Peng, P., Zhang, B., Huang, J., Xing, C., Liu, W., Sun, C., Guo, W., Yao, S., Ruan, W., Ning, G., Kong, X., & Feng, S. (2020). Identification of a circRNA-miRNA-mRNA network to explore the effects of circRNAs on pathogenesis and treatment of spinal cord injury. Life Sciences, 257, 118039. https://doi.org/10.1016/j.lfs.2020.118039
   PubMed Web of Science ®Google Scholar
• Plotnikov, M. B., & Plotnikova, T. M. (2021). Tyrosol as a neuroprotector: strong effects of a “weak” antioxidant. Current Neuropharmacology, 19(4), 434–448. https://doi.org/10.2174/1570159X18666200507082311
   PubMed Web of Science ®Google Scholar
• Ranasinghe, P., Galappaththy, P., Constantine, G. R., Jayawardena, R., Weeratunga, H. D., Premakumara, S., & Katulanda, P. (2017). Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: Study protocol for a randomized controlled trial. Trials, 18(1), 446. https://doi.org/10.1186/s13063-017-2192-0
   PubMedGoogle Scholar
• Ranasinghe, P., Jayawardana, R., Galappaththy, P., Constantine, G. R., de Vas Gunawardana, N., & Katulanda, P. (2012). Efficacy and safety of 'true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: A systematic review and meta-analysis. Diabetic Medicine, 29(12), 1480–1492. https://doi.org/10.1111/j.1464-5491.2012.03718.x
   PubMed Web of Science ®Google Scholar
• Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., Xu, X., Li, Y., Wang, Y., & Yang, L. (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6(1), 13. https://doi.org/10.1186/1758-2946-6-13
   PubMed Web of Science ®Google Scholar
• Saxton, R. A., Tsutsumi, N., Su, L. L., Abhiraman, G. C., Mohan, K., Henneberg, L. T., Aduri, N. G., Gati, C., & Garcia, K. C. (2021). Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10. Science (New York, N.Y.), 371(6535), eabc8433. https://doi.org/10.1126/science.abc8433
   PubMed Web of Science ®Google Scholar
• Schmidt, A. M. (2019). Diabetes mellitus and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 39(4), 558–568. https://doi.org/10.1161/ATVBAHA.119.310961
   PubMed Web of Science ®Google Scholar
• Short, W. D., Steen, E., Kaul, A., Wang, X., Olutoye, O. O., 2nd, Vangapandu, H. V., Templeman, N., Blum, A. J., Moles, C. M., Narmoneva, D. A., Crombleholme, T. M., Butte, M. J., Bollyky, P. L., Keswani, S. G., & Balaji, S. (2022). IL-10 promotes endothelial progenitor cell infiltration and wound healing via STAT3. Faseb Journal, 36(7), e22298.
   PubMed Web of Science ®Google Scholar
• Sidhu, H., & Capalash, N. (2021). Synergistic anti-cancer action of salicylic acid and cisplatin on HeLa cells elucidated by network pharmacology and in vitro analysis. Life Sciences, 282, 119802. https://doi.org/10.1016/j.lfs.2021.119802
   PubMed Web of Science ®Google Scholar
• Wang, X., & Zhao, L. (2016). Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway. Biochemical and Biophysical Research Communications, 473(2), 428–434. https://doi.org/10.1016/j.bbrc.2016.03.024
   PubMed Web of Science ®Google Scholar
• Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International Journal of Medical Sciences, 11(11), 1185–1200. https://doi.org/10.7150/ijms.10001
   PubMed Web of Science ®Google Scholar
• Wu, L., Meng, Y., Xu, Y., & Chu, X. (2022). Improved uptake and bioavailability of cinnamaldehyde via solid lipid nanoparticles for oral delivery. Pharmaceutical Development and Technology, 27(10), 1038–1048. https://doi.org/10.1080/10837450.2022.2147542
   PubMed Web of Science ®Google Scholar
• Xia, Q. D., Xun, Y., Lu, J. L., Lu, Y. C., Yang, Y. Y., Zhou, P., Hu, J., Li, C., & Wang, S. G. (2020). Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19. Cell Proliferation, 53(12), e12949.
   PubMed Web of Science ®Google Scholar
• Xiao, F., Zhou, C., & Cao, M. (2022). Effect of Huangqi Guizhi Wuwutang on diabetic peripheral neuropathy in mkr mice via regulating endoplasmic reticulum stress. Chinese Journal of Experimental Traditional Medical Formulae, 228(16), 1–8.
   Google Scholar
• Xu, J., Zhang, Z., Zhou, K., Li, Y., Wan, J., Mao, T., Ji, X., Liu, J., & Lin, Q. (2021). Integration of network pharmacology and molecular docking technology reveals the mechanism of the herbal pairing of Codonopsis Pilosula (Franch.) Nannf and Astragalus Membranaceus (Fisch.) Bge on chronic heart failure. Annals of Palliative Medicine, 10(7), 7942–7959. https://doi.org/10.21037/apm-21-1469
   PubMed Web of Science ®Google Scholar
• Yang, J. H., Shin, B. Y., Han, J. Y., Kim, M. G., Wi, J. E., Kim, Y. W., Cho, I. J., Kim, S. C., Shin, S. M., & Ki, S. H. (2014). Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes. Toxicology and Applied Pharmacology, 274(2), 293–301. https://doi.org/10.1016/j.taap.2013.10.026
   PubMed Web of Science ®Google Scholar
• Ye, J., Li, L., & Hu, Z. (2021). Exploring the molecular mechanism of action of Yinchen Wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation. BioMed Research International, 2021, 9965906–9965914. https://doi.org/10.1155/2021/9965906
   PubMed Web of Science ®Google Scholar
• Yong, Z., Xingqi, W., Jie, H., Rongfeng, H., & Xiaoqin, C. (2020). Formulation, production, in vitro release and in vivo pharmacokinetics of cinnamaldehyde sub-micron emulsions. Pharmaceutical Development and Technology, 25(6), 676–685. https://doi.org/10.1080/10837450.2020.1729800
   PubMed Web of Science ®Google Scholar
• Zepp, J., Wu, L., & Li, X. (2011). IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends in Immunology, 32(5), 232–239. https://doi.org/10.1016/j.it.2011.02.007
   PubMed Web of Science ®Google Scholar
• Zhang, X. Q., & Li, L. (2021). Biological function and clinical value of VPS13A in Pan-Cancer based on bioinformatics analysis. International Journal of General Medicine, 14, 6825–6838. https://doi.org/10.2147/IJGM.S330256
   PubMed Web of Science ®Google Scholar
• Zhang, X., Ramírez, C. M., Aryal, B., Madrigal-Matute, J., Liu, X., Diaz, A., Torrecilla-Parra, M., Suárez, Y., Cuervo, A. M., Sessa, W. C., & Fernández-Hernando, C. (2020). Cav-1 (Caveolin-1) deficiency increases autophagy in the endothelium and attenuates vascular inflammation and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(6), 1510–1522. https://doi.org/10.1161/ATVBAHA.120.314291
   PubMed Web of Science ®Google Scholar
• Zhao, Q., Zheng, B., Feng, P., & Li, X. (2021). A study to decipher the potential effects of butylphthalide against central nervous system diseases based on network pharmacology and molecular docking integration strategy. Evidence-Based Complementary and Alternative Medicine: ECAM, 2021, 6694698. https://doi.org/10.1155/2021/6694698
   PubMed Web of Science ®Google Scholar
• Zhou, X., Du, J., Liu, C., Zeng, H., Chen, Y., Liu, L., & Wu, D. (2021). A pan-cancer analysis of CD161, a potential new immune checkpoint. Frontiers in Immunology, 12, 688215. https://doi.org/10.3389/fimmu.2021.688215
   PubMedGoogle Scholar